All Work

Omor Ibne Ehsan

This 1 ETF Outperformed the VOO 7-to-1 This Year

The Vanguard S&P 500 ETF (NYSEARCA:VOO) is the most popular in terms of size, with over $775 billion in total assets under management. It has the same weightings and holdings as the S&P 500…

Omor Ibne Ehsan · 11 months ago

Don’t Buy SPY Until You Look at These 2 ETFs First

There is a tendency among many investors to hold the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) and nothing else. That’s completely fine if you want to be vanilla, but by doing so, you may…

Omor Ibne Ehsan · 11 months ago

Jim Cramer Is All in on These 3 Growth Stocks

Jim Cramer has often been seen as a figure with a “hit or miss” track record. But in 2025, his picks turned out remarkably successful so far, especially when it comes to growth stocks.…

Omor Ibne Ehsan · 11 months ago

Are Investors Done With Palantir? Here’s Where Is What’s Next

Palantir (NASDAQ:PLTR | PLTR Price Prediction) stock has been the hottest name this year, overtaking even Nvidia (NASDAQ:NVDA) at one point, in terms of publicity. However, things have been getting slower in recent months.…

Omor Ibne Ehsan · 11 months ago

Should You Buy META Stock Now?

Meta Platforms (NASDAQ:META | META Price Prediction) has had a terrific past few years, and the company has found what it was missing the most: growth. In 2022, META stock was down 76% from…

Omor Ibne Ehsan · 11 months ago

SPY Got Beat 3-To-1 By This ETF This Year

iShares Gold Trust ETF (NYSEARCA:IAU) had significantly outperformed SPDR S&P 500 ETF Trust (NYSEARCA:SPY) this year. While SPY has posted impressive gains of nearly 15% year-to-date—making this a stronger-than-average year for the S&P 500…

Omor Ibne Ehsan · 11 months ago

3 Dividend ETFs With Over 100% Upside Potential by 2027

Not every dividend ETF you buy needs to be boring. The vast majority of dividend ETFs you hold should certainly be ones that compound reliably over decades, but it’s also worth buying up those…

Omor Ibne Ehsan · 11 months ago

Billionaires Are Piling Into United Health Group and These 2 Stocks

UnitedHealth Group (NYSE:UNH | UNH Price Prediction), Bristol-Myers Squibb (NYSE:BMY) and Fiserv (NYSE:FI) have been getting plenty of attention from big name investors.  Every three months, the SEC’s 13F filings open a small window into those…

Omor Ibne Ehsan · 11 months ago

Double Your Money This Year With These 3 Small-Cap Growth Stocks

Everyone wishes they had bought companies like Google or NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) before they matured into the behemoths they are today. However, very few are willing to take the risk. The argument…

Omor Ibne Ehsan · 11 months ago

2 Dividend Stocks That Jim Cramer Wants Every Retiree to Own

Retirees and older individuals are among the biggest demographics who tune into Jim Cramer’s Mad Money show. You may disagree with Cramer’s investing methodology and critique his failures, but it’s undeniable that his opinions…

Omor Ibne Ehsan · 11 months ago

These 2 Dividend Stocks Are Trouncing Growth Stocks And Pay Monthly!

Most investors still equate dividends with sleepy quarterly payouts that barely outrun inflation, while the real action supposedly lives in high-octane growth stocks. That’s not always the case, and recent macroeconomic changes are expected…

Omor Ibne Ehsan · 11 months ago

3 Dividend Aristocrat Stocks You Should Never Sell

Dividend Aristocrat stocks are great for holding your portfolio together, in good times and bad times. Their underlying businesses have hiked dividend payouts for 25 consecutive years or more. Companies can’t keep their dividends…

Omor Ibne Ehsan · 11 months ago